Community oncology faces significant challenges from the Inflation Reduction Act's (IRA) drug pricing changes, risking ...

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

Should Medicare and Medicaid eventually cover new weight loss drugs such as Ozempic and Wegovy? This week, Audacy took a look ...

Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug ...

The Farina family was relieved when their matriarch, Gloria, qualified for Medicaid in 2023 after a grueling application process. The support allows Gloria, 91, to remain at her assisted-living ...

A new study suggests that weight-loss drugs may significantly reduce alcohol consumption in people with obesity.

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

When you first sign up for Medicare, you may come across many terms and abbreviations. Learning the definitions of these can help you understand Medicare better. Medicare information can be confusing.

Semaglutide, known primarily for diabetes management and weight reduction, is demonstrating remarkable cardiovascular benefits that begin surprisingly early in treatment and persist long-term.

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...

Wellabe, formerly Medico, offers solid discounts and low premiums in certain locations, but gets more customer complaints than average. Many, or all, of the products featured on this page are from ...

Novo Nordisk CEO Lars Fruergaard Jørgensen will step down as part of an accelerated leadership transition. Former CEO Lars ...